Thane Kreiner, the Biotech-Entrepreneur-Turned-Educator With 1 Billion People on His Mind

some pretty impressive metrics through its history, which mostly pre-dates Kreiner’s arrival in September 2010. The program has mentored 120 entrepreneurs since 2003, and 96 percent are still in business, with more than half of them scaling up, Kreiner says. When he arrived, the program didn’t have aggregate data on how many people’s lives were touched by these businesses, so Santa Clara gathered it. They found that 74 million people had been affected, more than anybody had anticipated, Kreiner says.

That’s when Kreiner resolved to set a goal of nurturing businesses that affect 1 billion people by 2020.

One of the best alumni of the program, Kreiner says, is a company called Husk Power Systems, in the state of Bihar in eastern India. Husk, like the name suggests, is seeking to take advantage of tons of rice husks that get discarded in poor regions, and use that source of biomass to generate electricity. Husk takes 45 million metric tons of rice husks that are available in villages, and runs them through high-temperature “gasifiers,” which drive generators that can provide lighting to rural areas that don’t have access to electricity on the grid, Kreiner says. These local gasifiers can provide jobs, and electricity to about 250 to 500 households each, enabling people in those places to do other productive things, Kreiner says. And this isn’t a feel-good project subsidized by government or philanthropists—it’s a sustainable for-profit business, Kreiner says.

That’s just one example of a big idea with potential to spread, since an estimated 1.5 billion people have no access to electricity, and another 1 billion have off-and-on access, Kreiner says. Clean water is basic necessity for health, which about 1 billion people around the world don’t have regular access to.

Of course, these problems are huge, and awfully daunting for any startup to try to make a meaningful dent. There’s not much in the way of capital to help scale up these ideas, like there is in the U.S. for new tech, biotech, or cleantech companies. But Kreiner says he’s convinced that Santa Clara, a private Catholic school with a little more than 5,000 undergrads, can actually have an impact. That’s partly because social entrepreneurship speaks directly to the school’s Jesuit mission, which Kreiner says is to “create a more just, humane, and sustainable world.” And even more importantly, because Santa Clara is a Jesuit school, which means it has a network with the other 27 Jesuit universities in the U.S., and more around the world. Kreiner isn’t personally a Catholic, but he says his personal values are completely aligned with those of the school. And he says the school’s deep set of beliefs are a critical motivating force for what he’s trying to do.

“A lot of universities are trying to create good in the world, but there are very few outside the Jesuit university network that are so strongly mission aligned toward service to the poor, and creating a more just and humane world,” Kreiner says. “It’s the mission of the whole university, not just a small group of people.”

If all goes according to plan, Santa Clara will help replicate its incubator program for entrepreneurs at other Jesuit schools around the world, and customize them for local contexts. That’s the way Kreiner intends to reach those 1 billion people, way beyond the academic halls of Santa Clara. Even without all the money and perks he could be raking in at a company, he insists that what he’s doing now is a once-in-a-lifetime opportunity, the kind of thing he’s been training to do for years.

“I always imagined at some point in my life, I’d focus on science and technology for social benefit, as opposed to returns for VCs and their LPs,” Kreiner says. “I had anticipated it would be five to 10 years down the road. When this came by, I felt like I couldn’t pass it up. It was a once in a lifetime opportunity to make a huge difference.”

Author: Luke Timmerman

Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.